First-ever ACG recommendations establish evidence-based protocols for diagnosing and managing gastric atrophy, intestinal metaplasia, and dysplasia, addressing significant cancer disparities in high-risk U.S. populations
"Chronic ethanol intake, through one of its main metabolic products, acetaldehyde, causes pathological changes in the gastrointestinal tract, liver, pancreas, and gallbladder. Even moderate amounts of alcohol may increase the risk of cancers, such as colorectal cancer."
Cabozantinib significantly reduced disease progression risk in patients with advanced neuroendocrine tumors: A 62% lower risk in extrapancreatic NETs and 77% in pancreatic NETs, study authors report.